Alembic Pharmaceuticals said that it has received final approval from the US Food & Drug Administration (US FDA) for its abbreviated new drug application (ANDA) Dabigatran Etexilate Capsules.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
